POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Seq. Identity (%)	View	Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_A_1LDA501_0 (CYTOSINE DEAMINASE)	1cjy	PROTEIN (CYTOSOLIC PHOSPHOLIPASE A2) (Homo sapiens)	5 / 12	ILE A 571 HIS A 639 GLU A 589 ASP A 575 SER A 577	None	1.43A	20.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_A_1LDA501_0 (CYTOSINE DEAMINASE)	2ctm	VIGILIN (Homo sapiens)	5 / 12	HIS A  28 PHE A  52 ILE A  50 GLU A  83 LEU A  80	None	1.42A	14.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_A_1LDA501_0 (CYTOSINE DEAMINASE)	2rjq	ADAMTS-5 (Homo sapiens)	5 / 12	LEU A 291 ILE A 363 LEU A 287 ASP A 276 SER A 278	None	1.42A	22.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_A_1LDA501_0 (CYTOSINE DEAMINASE)	3b6v	KINESIN-LIKE PROTEIN KIF3C (Homo sapiens)	5 / 12	GLN A 108 ILE A 120 GLU A 147 LEU A 156 SER A 216	None	1.38A	23.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_A_1LDA501_0 (CYTOSINE DEAMINASE)	3bdw	NKG2-A/NKG2-B TYPE II INTEGRAL MEMBRANE PROTEIN (Homo sapiens)	5 / 12	LEU B 211 PHE B 194 HIS B 196 GLU B 162 LEU B 166	None	1.13A	14.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_A_1LDA501_0 (CYTOSINE DEAMINASE)	3e0l	GUANINE DEAMINASE (Homo sapiens)	5 / 12	HIS A  84 HIS A 238 HIS A 277 LEU A 306 ASP A 328	ZN  A1452 (-3.1A) ZN  A1452 (-3.2A) None None ZN  A1452 (-2.8A)	0.44A	23.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_A_1LDA501_0 (CYTOSINE DEAMINASE)	3e0l	GUANINE DEAMINASE (Homo sapiens)	5 / 12	HIS A  84 LEU A 306 HIS A 238 HIS A 277 ASP A 328	ZN  A1452 (-3.1A) None ZN  A1452 (-3.2A) None ZN  A1452 (-2.8A)	1.30A	23.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_A_1LDA501_0 (CYTOSINE DEAMINASE)	3lgg	ADENOSINE DEAMINASE CECR1 (Homo sapiens)	5 / 12	HIS A  88 HIS A 330 HIS A 358 LEU A 389 ASP A 415	CFE  A 513 ( 3.3A) ZN  A 512 ( 3.5A) CFE  A 513 ( 4.3A) None CFE  A 513 ( 2.8A)	0.27A	22.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_A_1LDA501_0 (CYTOSINE DEAMINASE)	3lgg	ADENOSINE DEAMINASE CECR1 (Homo sapiens)	5 / 12	HIS A  88 LEU A 389 HIS A 330 HIS A 358 ASP A 415	CFE  A 513 ( 3.3A) None ZN  A 512 ( 3.5A) CFE  A 513 ( 4.3A) CFE  A 513 ( 2.8A)	1.27A	22.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_A_1LDA501_0 (CYTOSINE DEAMINASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	LEU A 425 PHE A 409 ILE A 380 GLU A 449 LEU A 447	None	1.39A	23.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_B_1LDB501_0 (CYTOSINE DEAMINASE)	1sjq	POLYPYRIMIDINE TRACT-BINDING PROTEIN 1 (Homo sapiens)	5 / 12	HIS A  20 LEU A  47 ILE A  26 LEU A  94 SER A  89	None	1.47A	14.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_B_1LDB501_0 (CYTOSINE DEAMINASE)	2ctm	VIGILIN (Homo sapiens)	5 / 12	HIS A  28 PHE A  52 ILE A  50 GLU A  83 LEU A  80	None	1.44A	14.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_B_1LDB501_0 (CYTOSINE DEAMINASE)	2r3v	MEVALONATE KINASE (Homo sapiens)	5 / 12	LEU A 305 ILE A 271 HIS A  17 GLU A  19 LEU A 331	None	1.39A	23.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_B_1LDB501_0 (CYTOSINE DEAMINASE)	2rjq	ADAMTS-5 (Homo sapiens)	5 / 12	LEU A 291 ILE A 363 LEU A 287 ASP A 276 SER A 278	None	1.39A	22.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_B_1LDB501_0 (CYTOSINE DEAMINASE)	3bdw	NKG2-A/NKG2-B TYPE II INTEGRAL MEMBRANE PROTEIN (Homo sapiens)	5 / 12	LEU B 211 PHE B 194 HIS B 196 GLU B 162 LEU B 166	None	1.12A	14.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_B_1LDB501_0 (CYTOSINE DEAMINASE)	3e0l	GUANINE DEAMINASE (Homo sapiens)	5 / 12	HIS A  84 HIS A 238 GLU A 241 LEU A 306 ASP A 328	ZN  A1452 (-3.1A) ZN  A1452 (-3.2A) None None ZN  A1452 (-2.8A)	0.48A	23.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_B_1LDB501_0 (CYTOSINE DEAMINASE)	3lgg	ADENOSINE DEAMINASE CECR1 (Homo sapiens)	5 / 12	HIS A  88 HIS A 330 GLU A 333 LEU A 389 ASP A 415	CFE  A 513 ( 3.3A) ZN  A 512 ( 3.5A) CFE  A 513 (-3.0A) None CFE  A 513 ( 2.8A)	0.37A	22.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_B_1LDB501_0 (CYTOSINE DEAMINASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	LEU A 425 PHE A 409 ILE A 380 GLU A 449 LEU A 447	None	1.39A	23.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_C_1LDC501_0 (CYTOSINE DEAMINASE)	1sjq	POLYPYRIMIDINE TRACT-BINDING PROTEIN 1 (Homo sapiens)	5 / 12	HIS A  20 LEU A  47 ILE A  26 LEU A  94 SER A  89	None	1.46A	14.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_C_1LDC501_0 (CYTOSINE DEAMINASE)	2ctm	VIGILIN (Homo sapiens)	5 / 12	HIS A  28 PHE A  52 ILE A  50 GLU A  83 LEU A  80	None	1.43A	14.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_C_1LDC501_0 (CYTOSINE DEAMINASE)	2r3v	MEVALONATE KINASE (Homo sapiens)	5 / 12	LEU A 305 ILE A 271 HIS A  17 GLU A  19 LEU A 331	None	1.38A	23.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_C_1LDC501_0 (CYTOSINE DEAMINASE)	2rjq	ADAMTS-5 (Homo sapiens)	5 / 12	LEU A 291 ILE A 363 LEU A 287 ASP A 276 SER A 278	None	1.41A	22.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_C_1LDC501_0 (CYTOSINE DEAMINASE)	3b6v	KINESIN-LIKE PROTEIN KIF3C (Homo sapiens)	5 / 12	GLN A 108 ILE A 120 GLU A 147 LEU A 156 SER A 216	None	1.39A	23.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_C_1LDC501_0 (CYTOSINE DEAMINASE)	3bdw	NKG2-A/NKG2-B TYPE II INTEGRAL MEMBRANE PROTEIN (Homo sapiens)	5 / 12	LEU B 211 PHE B 194 HIS B 196 GLU B 162 LEU B 166	None	1.13A	14.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_C_1LDC501_0 (CYTOSINE DEAMINASE)	3e0l	GUANINE DEAMINASE (Homo sapiens)	5 / 12	HIS A  84 HIS A 238 GLU A 241 LEU A 306 ASP A 328	ZN  A1452 (-3.1A) ZN  A1452 (-3.2A) None None ZN  A1452 (-2.8A)	0.48A	23.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_C_1LDC501_0 (CYTOSINE DEAMINASE)	3lgg	ADENOSINE DEAMINASE CECR1 (Homo sapiens)	5 / 12	HIS A  88 HIS A 330 GLU A 333 LEU A 389 ASP A 415	CFE  A 513 ( 3.3A) ZN  A 512 ( 3.5A) CFE  A 513 (-3.0A) None CFE  A 513 ( 2.8A)	0.38A	22.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_C_1LDC501_0 (CYTOSINE DEAMINASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	LEU A 425 PHE A 409 ILE A 380 GLU A 449 LEU A 447	None	1.38A	23.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_D_1LDD501_0 (CYTOSINE DEAMINASE)	1sjq	POLYPYRIMIDINE TRACT-BINDING PROTEIN 1 (Homo sapiens)	5 / 12	HIS A  20 LEU A  47 ILE A  26 LEU A  94 SER A  89	None	1.48A	14.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_D_1LDD501_0 (CYTOSINE DEAMINASE)	2ctm	VIGILIN (Homo sapiens)	5 / 12	HIS A  28 PHE A  52 ILE A  50 GLU A  83 LEU A  80	None	1.42A	14.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_D_1LDD501_0 (CYTOSINE DEAMINASE)	2r3v	MEVALONATE KINASE (Homo sapiens)	5 / 12	LEU A 305 ILE A 271 HIS A  17 GLU A  19 LEU A 331	None	1.40A	23.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_D_1LDD501_0 (CYTOSINE DEAMINASE)	2rjq	ADAMTS-5 (Homo sapiens)	5 / 12	LEU A 291 ILE A 363 LEU A 287 ASP A 276 SER A 278	None	1.42A	22.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_D_1LDD501_0 (CYTOSINE DEAMINASE)	3bdw	NKG2-A/NKG2-B TYPE II INTEGRAL MEMBRANE PROTEIN (Homo sapiens)	5 / 12	LEU B 211 PHE B 194 HIS B 196 GLU B 162 LEU B 166	None	1.12A	14.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_D_1LDD501_0 (CYTOSINE DEAMINASE)	3e0l	GUANINE DEAMINASE (Homo sapiens)	5 / 12	HIS A  84 HIS A 238 GLU A 241 LEU A 306 ASP A 328	ZN  A1452 (-3.1A) ZN  A1452 (-3.2A) None None ZN  A1452 (-2.8A)	0.49A	23.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_D_1LDD501_0 (CYTOSINE DEAMINASE)	3lgg	ADENOSINE DEAMINASE CECR1 (Homo sapiens)	5 / 12	HIS A  88 HIS A 330 GLU A 333 LEU A 389 ASP A 415	CFE  A 513 ( 3.3A) ZN  A 512 ( 3.5A) CFE  A 513 (-3.0A) None CFE  A 513 ( 2.8A)	0.38A	22.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_E_1LDE501_0 (CYTOSINE DEAMINASE)	1sjq	POLYPYRIMIDINE TRACT-BINDING PROTEIN 1 (Homo sapiens)	5 / 12	HIS A  20 LEU A  47 ILE A  26 LEU A  94 SER A  89	None	1.46A	14.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_E_1LDE501_0 (CYTOSINE DEAMINASE)	2ctm	VIGILIN (Homo sapiens)	5 / 12	HIS A  28 PHE A  52 ILE A  50 GLU A  83 LEU A  80	None	1.43A	14.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_E_1LDE501_0 (CYTOSINE DEAMINASE)	2r3v	MEVALONATE KINASE (Homo sapiens)	5 / 12	LEU A 305 ILE A 271 HIS A  17 GLU A  19 LEU A 331	None	1.39A	23.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_E_1LDE501_0 (CYTOSINE DEAMINASE)	2rjq	ADAMTS-5 (Homo sapiens)	5 / 12	LEU A 291 ILE A 363 LEU A 287 ASP A 276 SER A 278	None	1.38A	22.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_E_1LDE501_0 (CYTOSINE DEAMINASE)	3bdw	NKG2-A/NKG2-B TYPE II INTEGRAL MEMBRANE PROTEIN (Homo sapiens)	5 / 12	LEU B 211 PHE B 194 HIS B 196 GLU B 162 LEU B 166	None	1.10A	14.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_E_1LDE501_0 (CYTOSINE DEAMINASE)	3e0l	GUANINE DEAMINASE (Homo sapiens)	5 / 12	HIS A  84 HIS A 238 GLU A 241 LEU A 306 ASP A 328	ZN  A1452 (-3.1A) ZN  A1452 (-3.2A) None None ZN  A1452 (-2.8A)	0.49A	23.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_E_1LDE501_0 (CYTOSINE DEAMINASE)	3lgg	ADENOSINE DEAMINASE CECR1 (Homo sapiens)	5 / 12	HIS A  88 HIS A 330 GLU A 333 LEU A 389 ASP A 415	CFE  A 513 ( 3.3A) ZN  A 512 ( 3.5A) CFE  A 513 (-3.0A) None CFE  A 513 ( 2.8A)	0.37A	22.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_E_1LDE501_0 (CYTOSINE DEAMINASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	LEU A 425 PHE A 409 ILE A 380 GLU A 449 LEU A 447	None	1.40A	23.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_F_1LDF502_0 (CYTOSINE DEAMINASE)	2ctm	VIGILIN (Homo sapiens)	5 / 12	HIS A  28 PHE A  52 ILE A  50 GLU A  83 LEU A  80	None	1.42A	14.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_F_1LDF502_0 (CYTOSINE DEAMINASE)	2r3v	MEVALONATE KINASE (Homo sapiens)	5 / 12	LEU A 305 ILE A 271 HIS A  17 GLU A  19 LEU A 331	None	1.39A	23.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_F_1LDF502_0 (CYTOSINE DEAMINASE)	2rjq	ADAMTS-5 (Homo sapiens)	5 / 12	LEU A 291 ILE A 363 LEU A 287 ASP A 276 SER A 278	None	1.37A	22.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_F_1LDF502_0 (CYTOSINE DEAMINASE)	3bdw	NKG2-A/NKG2-B TYPE II INTEGRAL MEMBRANE PROTEIN (Homo sapiens)	5 / 12	LEU B 211 PHE B 194 HIS B 196 GLU B 162 LEU B 166	None	1.13A	14.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_F_1LDF502_0 (CYTOSINE DEAMINASE)	3e0l	GUANINE DEAMINASE (Homo sapiens)	5 / 12	HIS A  84 HIS A 238 GLU A 241 LEU A 306 ASP A 328	ZN  A1452 (-3.1A) ZN  A1452 (-3.2A) None None ZN  A1452 (-2.8A)	0.47A	23.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_F_1LDF502_0 (CYTOSINE DEAMINASE)	3lgg	ADENOSINE DEAMINASE CECR1 (Homo sapiens)	5 / 12	HIS A  88 HIS A 330 GLU A 333 LEU A 389 ASP A 415	CFE  A 513 ( 3.3A) ZN  A 512 ( 3.5A) CFE  A 513 (-3.0A) None CFE  A 513 ( 2.8A)	0.37A	22.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R88_F_1LDF502_0 (CYTOSINE DEAMINASE)	4kt1	LEUCINE-RICH REPEAT-CONTAINING G-PROTEIN COUPLED RECEPTOR 4 (Homo sapiens)	5 / 12	LEU A 425 PHE A 409 ILE A 380 GLU A 449 LEU A 447	None	1.40A	23.87